GLP-1 Shots: Every Other Week – Dosage & Timing
Summary of GLP-1 Dosage Reduction Study & Expert opinions
This article discusses a recent analysis exploring whether people taking GLP-1 medications (Ozempic/semaglutide or Zepbound/tirzepatide) for weight loss can successfully reduce their dosing frequency from weekly to every other week without regaining weight.
Key Findings:
* Minimal Weight Regain: After switching to every-other-week injections, participants lost an additional 2-4 pounds on average, and body fat loss remained stable.
* Stable Metabolic Health: Improvements in blood sugar, triglycerides, and blood pressure where maintained with reduced dosing.
* high Maintenance Rate: The vast majority (26 out of 30) of participants successfully maintained their weight loss with the reduced schedule, with some even extending the dosing interval further.
* Muscle Mass Preservation: The ratio of fat to muscle mass remained consistent.
Expert Opinions:
* Dr. Yuval Pinto (Johns Hopkins Medicine): The findings are promising but preliminary due to the small sample size and retrospective nature of the study. he emphasizes the importance of considering other factors influencing weight (sleep apnea, diet, exercise, other medications).
* Dr. Peminda Cabandugama (Cleveland Clinic): The results are somewhat surprising given the drug’s half-life (5 days), suggesting the standard weekly dosing already “stretches” the medication’s effect. Also notes the small study size.
Overall Implications:
The study suggests that reducing the frequency of GLP-1 injections may be a viable option for some individuals to maintain weight loss. Though, larger, randomized studies are needed to confirm these findings and determine which patients are most likely to succeed with a reduced dosing schedule.Individual metabolism and kidney/liver function may play a role in prosperous de-escalation.